Skip to content
Molecules
SEKISUI XenoTech DD Blog Logo

Author: Dr. Maciej Czerwinski

SEKISUI XenoTech Joins Fight Against Liver Disease

SEKISUI XenoTech is committed to furthering the knowledge surrounding hepatic diseases, such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic...

Drug-Drug Interaction (DDI) Prediction Models Following In Vitro Studies in Preclinical Development

In preclinical development, a drug will be evaluated for potential to cause a drug-drug interaction (DDI) using in vitro experiments and then calculations that...

Can Interactions Between Therapeutic Proteins and Small Molecule Drugs Be Evaluated In Vitro?

The mechanisms of clearance for small molecule drugs and therapeutic proteins are fundamentally distinct and therefore therapeutic proteins are generally not...

New Liver Tissue Microarrays Available – What Would Benefit Your Research?

As technology evolves to better meet needs in exploration of drug metabolism pathways and disease mechanisms, familiarization with appropriate and...

New Liver Disease Resource and Other Research Biobank News

SEKISUI XenoTech is committed to furthering the knowledge surrounding hepatic diseases, which affects one out of four people worldwide, such...

Building a reputation for excellence

We are proud to have some of the brightest minds in DDI & DMPK research in our labs. Browse our new Meet Our Experts page where you can find bios for some of our most seasoned scientists working on both Contract Research & Test Systems teams.

Team of DMPK researchers

Read more about the research performed at SEKIUI XenoTech

Access ADME™ is our all-inclusive repository for scientific resources. Find scientific posters, publications, blog posts, webinars and more relating to ADME/DMPK, drug-drug interactions and other studies.

Access ADME